Startseite Medizin Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene

  • Hakan Doneray EMAIL logo , Jayne Houghton , Kadir Serafettin Tekgunduz , Ferat Balkir und Ibrahim Caner
Veröffentlicht/Copyright: 23. Oktober 2013

Abstract

Mutations in the KCNJ11 gene are responsible for the majority of permanent neonatal diabetes mellitus (PNDM) cases. Some mutations in this gene, including p.Q52R, are associated with the developmental delay, epilepsy, neonatal diabetes (DEND) syndrome. We describe a patient with PNDM who had no neurological finding although she was determined to have a novel mutation (p.Q52L) in the same residue of the KCNJ11 as in the previously reported cases with DEND syndrome. This case suggests that not all Q52 mutations in the KCNJ11 gene are necessarily related to DEND syndrome.


Corresponding author: Hakan Doneray, Department of Pediatric Endocrinology, Ataturk University Faculty of Medicine, Erzurum, Turkey; and Haci Salih Efendi M. Ebu Ishak C. TEMA sitesi A Blk. 4/15, Yenisehir, 25070, Erzurum, Turkey, Phone: +90 535 944 43 07, Fax: +90 442 236 13 01, E-mail:

Acknowledgments

We thank Professor Hattersley for his help with the manuscript and Professor Ellard of the University of Exeter, Medical School, who provided the complimentary molecular genetic testing (see www.diabetesgenes.org). The Wellcome Trust funded the genetic testing.

References

1. Shield JP. Neonatal diabetes. Horm Res 2007;68(Suppl 5):32–66.Suche in Google Scholar

2. Slingerland AS, Shields BM, Flanagan SE, Bruining GJ, Noordam K, et al. Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births. Diabetologia 2009;52:1683–85.Suche in Google Scholar

3. Gloyn AL, Pearson ER, Antcliff JF, Proks P, Bruining GJ, et al. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes. N Engl J Med 2004;350:1838–49.Suche in Google Scholar

4. Gloyn AL, Diatloff-Zito C, Edghill EL, Bellanne-chantelot C, Nivot S, et al. KCNJ11 activating mutations are associated with developmental delay, epilepsy and neonatal diabetes syndrome and other neurological features. Eur J Hum Genet 2006;14:824–30.Suche in Google Scholar

5. Masia R, Koster JC, Tumini S, Chiarelli F, Colombo C, et al. An ATP-binding mutation (G334D) in KCNJ11 is associated with a sulfonylurea-insensitive form of developmental delay, epilepsy, and neonatal diabetes. Diabetes 2007;56:328–36.Suche in Google Scholar

6. Shimomura K, Horster F, de Wet H, Flanagan SE, Ellard S, et al. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain. Neurology 2007;69:1342–9.Suche in Google Scholar

7. Flanagan SE, Edghill EL, Gloyn AL, Ellard S, Hattersley AT. Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype. Diabetologia 2006;49:1190–7.Suche in Google Scholar

8. Sumnik Z, Kolouskova S, Wales JK, Komarek V, Cinek O. Sulphonylurea treatment does not improve psychomotor development in children with KCNJ11 mutations causing permanent neonatal diabetes mellitus accompanied by developmental delay and epilepsy (DEND syndrome). Diabet Med 2007;24:1176–8.Suche in Google Scholar

9. Lubchenco LO, Hansman C, Boyd E. Intrauterine growth in length and head circumference as estimated from live births at gestational ages from 26 to 42 weeks. Pediatrics 1966;37:403–8.Suche in Google Scholar

10. Shield JP. Neonatal diabetes: how research unravelling the genetic puzzle has both widened our understanding of pancreatic development whilst improving children’s quality of life. Horm Res 2007;67:77–83.Suche in Google Scholar

11. De León DD, Stanley CA. Permanent neonatal diabetes mellitus. In: Pagon RA, Bird TD, Dolan CR, Stephens K, Adam MP, editors. SourceGeneReviews™ [Internet]. Seattle: University of Washington, Seattle, 1993–2008 [updated July 5, 2011].Suche in Google Scholar

12. Lango Allen H, Flanagan SE, Shaw-Smith C, De Franco E, Akerman I, et al. GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nat Genet 2011;44:20–2.Suche in Google Scholar

13. Hattersley A, Bruining J, Shield J, Njolstad P, Donaghue K. ISPAD Clinical Practice Consensus Guidelines 2006–2007. The diagnosis and management of monogenic diabetes in children. Pediatr Diabetes 2006;7:352–60.Suche in Google Scholar

14. Hattersley AT, Ashcroft FM. Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy. Diabetes 2005;54:2503–13.Suche in Google Scholar

15. Shaw ND, Majzoub JA. Permanent neonatal diabetes in a patient with a KCNJ11/Q52R mutation accompanied by intermittent hypoglycemia and liver failure. Int J Pediatr Endocrinol 2009;2009:453240.Suche in Google Scholar

16. Shimomura K, Girard CA, Proks P, Nazim J, Lippiat JD, et al. Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects. Diabetes 2006;55:1705–12.Suche in Google Scholar

17. Woolley SL, Saranga S. Neonatal diabetes mellitus: a rare but important diagnosis in the critically ill infant. Eur J Emerg Med 2006;13:349–51.Suche in Google Scholar

Received: 2013-2-18
Accepted: 2013-9-9
Published Online: 2013-10-23
Published in Print: 2014-03-01

©2014 by Walter de Gruyter Berlin Boston

Artikel in diesem Heft

  1. Masthead
  2. Masthead
  3. Images in pediatric endocrinology
  4. Leprechaunism (Donohue syndrome): report of a case in a newborn
  5. Original articles
  6. Children and adolescents with type 1 diabetes in Germany are more overweight than healthy controls: results comparing DPV database and CrescNet database
  7. Age of onset of pubertal maturation of Thai boys
  8. Plasma leptin and adiponectin concentrations correlate with cardiometabolic risk and systemic inflammation in healthy, non-obese children
  9. Early differentiation between good and poor response to growth hormone therapy in short children born small for gestational age (SGA) to improve the outcome of poor responders
  10. Children and adolescents with type 1 diabetes mellitus have a sixfold greater risk for prolonged QTc interval
  11. Effect of micronutrient supplementation on height velocity of underprivileged girls in comparison with un-supplemented healthy controls
  12. Insulin resistance in young adults born small for gestational age (SGA)
  13. The effect of childhood obesity on cardiac functions
  14. Adiponectin serum concentrations in newborn at delivery appear to be of fetal origin
  15. Thalassaemic Osteopathy: a cross-sectional preliminary study from Sri Lanka
  16. Health-related quality of life in Turner syndrome and the influence of key features
  17. Clinical analysis on 33 patients with hypothalamic syndrome in Chinese children
  18. The relationship between thyroid dose and diagnosis of primary hypothyroidism in pediatric brain tumor patients receiving craniospinal irradiation
  19. Molecular characterization of Chilean patients with a clinical diagnosis of Noonan syndrome
  20. Expensive therapies in children: benefit versus cost of combined treatment of recombinant human growth hormone and gonadotropin-releasing hormone analogue in girls with poor height potential
  21. The absence of mutations in homeobox candidate genes HOXA3, HOXB3, HOXD3 and PITX2 in familial and sporadic thyroid hemiagenesis
  22. A truncating DUOX2 mutation (R434X) causes severe congenital hypothyroidism
  23. Heterozygous GHR gene mutation in a child with idiopathic short stature
  24. A novel compound mutation of CYP27B1 in a Chinese family with vitamin D-dependent rickets type 1A
  25. A de novo mutation of DAX1 in a boy with congenital adrenal hypoplasia without hypogonadotropic hypogonadism
  26. Patient reports
  27. Hypercalcemia and osteolytic lesions as presenting symptoms of acute lymphoblastic leukemia in childhood. The use of zoledronic acid and review of the literature
  28. Preterm ovarian hyperstimulation syndrome presented with vaginal bleeding: a case report
  29. Pituitary stalk lesion in a 13-year-old female
  30. Radiologic manifestation of a BCS1L-mutated patient
  31. Permanent neonatal diabetes mellitus caused by a novel mutation in the KCNJ11 gene
  32. NKX2-1 mutations in brain-lung-thyroid syndrome: a case series of four patients
  33. A teenage boy with hypocalcemia after radioablation for Graves’ disease
  34. Short communication
  35. A common thyroid peroxidase gene mutation (G319R) in Turkish patients with congenital hypothyroidism could be due to a founder effect
  36. Letter to the Editor
  37. Endometriosis and migraine: what is there behind the scenes?
  38. 10.1515/jpem-2014-0999
Heruntergeladen am 20.1.2026 von https://www.degruyterbrill.com/document/doi/10.1515/jpem-2013-0068/html
Button zum nach oben scrollen